Perturbed proteostasis in autism spectrum disorders. (2016)
Attributed to:
Targeting ERK and mTOR for the treatment of fragile X syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/jnc.13723
PubMed Identifier: 27365114
Publication URI: http://europepmc.org/abstract/MED/27365114
Type: Journal Article/Review
Volume: 139
Parent Publication: Journal of neurochemistry
Issue: 6
ISSN: 0022-3042